|
|
News Breaks | | | | November 15, 2012 | | 08:57 EDT |  | TRGT, ARQL | Targacept names Stephen A. Hill, M.D., president and CEO
Dr. Hill is expected to start with Targacept (TRGT) on December 1 and will also join Targacept’s Board of Directors. Dr. Hill brings over 20 years of industry experience to the role, having served previously as President and Chief Executive Officer of Solvay Pharmaceuticals, Inc. and ArQule (ARQL). Upon Dr. Hill joining Targacept, the previously formed Office of the Chairman will be dissolved. | |
|
News For TRGT;ARQL From The Last 14 Days Check below for free stories on TRGT;ARQL the last two weeks. |
|
|
| There are no results for TRGT;ARQL |
|
|
|
|
|
|
